ClinVar Miner

Submissions for variant NM_001378452.1(ITPR1):c.4421C>T (p.Thr1474Ile)

gnomAD frequency: 0.00048  dbSNP: rs188558398
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Athena Diagnostics RCV000992197 SCV001144268 benign not provided 2019-02-25 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001147931 SCV001308788 likely benign Autosomal dominant cerebellar ataxia 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.
Institute of Human Genetics, University of Leipzig Medical Center RCV001262674 SCV001440624 uncertain significance Spinocerebellar ataxia type 15/16 2019-01-01 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000992197 SCV003244918 likely benign not provided 2024-01-17 criteria provided, single submitter clinical testing
Ambry Genetics RCV002549783 SCV003618553 uncertain significance Inborn genetic diseases 2021-08-14 criteria provided, single submitter clinical testing Unlikely to be causative of ITPR1-related spinocerebellar ataxia (AD) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
CeGaT Center for Human Genetics Tuebingen RCV000992197 SCV005093752 uncertain significance not provided 2024-07-01 criteria provided, single submitter clinical testing
GeneDx RCV000992197 SCV005326091 uncertain significance not provided 2023-11-17 criteria provided, single submitter clinical testing Identified in a patient with mitochondrial disease with another variant in ITPR1, phase unknown, who is also reported to have a variant in a gene that causes MELAS, which was thought to be a closer phenotypic fit (PMID: 32980267); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 32980267)
Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille RCV001251784 SCV001427526 likely benign Intellectual disability 2019-01-01 no assertion criteria provided clinical testing
PreventionGenetics, part of Exact Sciences RCV003943298 SCV004758108 likely benign ITPR1-related disorder 2022-05-19 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.